Both in Pharmaceuticals
ArriVent BioPharma vs Olema Pharmaceuticals
Over the past year AVBP returned −26.9% and OLMA returned −12.2%; their daily moves had a correlation of 0.08.
AVBP −26.9% OLMA −12.2%Growth of $1, one year, split-adjusted
| Metric | AVBP | OLMA |
|---|---|---|
| Price | $12.87 | $7.40 |
| Market cap | $634.6M | $647.0M |
| Today | −1.15% | +0.61% |
| 1 month | −14.7% | −6.6% |
| 6 months | −56.5% | −51.3% |
| Year to date | −36.0% | −70.4% |
| 1 year | −26.9% | −12.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $373.1M | $458.1M |
| Dividend yield | — | — |
| Volatility (60d) | 154.3% | 54.7% |
| Short % of float | 20.3% | 24.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).